Long-Term Support for Sustainable Results and Continued Metabolic Stability Transitioning From Early Medication Adjustment to Steady Progress Once a patient has moved through the titration phase and reached a stable, therapeutic dose, the focus of care shifts from dose escalation to long-term maintenance
GLP-1-associated vision problems linked to sudden glucose drops Like the JAMA Ophthalmology study, 5 the AOA report suggests the vision problems are connected to how quickly these drugs lower blood sugar
Preclinical studies for IR intervention In recent years, accumulating preclinical studies on the intervention of IR have been reported, which have important reference significance for the development of new drugs
These medications help stabilize blood sugar levels, promote weight loss, and even improve heart health
, , , 1
Choosing the right one involves thinking not just about initial weight loss but about long-term tolerability, cost sustainability, and availability